Table of contents

Clinical and epidemiological research

• Extended report: The global burden of low back pain: estimates from the Global Burden of Disease 2010 study (24 March, 2014) Free

  Damian Hoy, Lyn March, Peter Brooks, Fiona Blyth, Anthony Woolf, Christopher Bain, Gail Williams, Emma Smith, Theo Vos, Jan Barendregt, Chris Murray, Roy Burstein, Rachelle Buchbinder
• Extended report: The global burden of occupationally related low back pain: estimates from the Global Burden of Disease 2010 study (24 March, 2014)

  T Driscoll, G Jacklyn, J Orchard, E Passmore, T Vos, G Freedman, S Lim, L Punnett
• Extended report: The global burden of musculoskeletal conditions for 2010: an overview of methods (18 February, 2014)

  Damian G Hoy, Emma Smith, Marita Cross, Lidia Sanchez-Riera, Rachelle Buchbinder, Fiona M Blyth, Peter Brooks, Anthony D Woolf, Richard H Osborne, Marlene Fransen, Tim Driscoll, Theo Vos, Jed D Blore, Chris Murray, Nicole Johns, Mohsen Naghavi, Emily Carnahan, Lyn M March
• Extended report: Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial (30 January, 2014)

  Christopher Ritchlin, Proton Rahman, Arthur Kavanaugh, Iain B McInnes, Lluis Puig, Shu Li, Yuhua Wang, Yaung-Kaung Shen, Mittie K Doyle, Alan M Mendelsohn, Alice B Gottlieb, on behalf of the PSUMMIT 2 Study Group
• Extended report: Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials (19 February, 2014)

  Arthur Kavanaugh, Christopher Ritchlin, Proton Rahman, Lluis Puig, Alice B Gottlieb, Shu Li, Yuhua Wang, Lenore Noonan, Carrie Brodmerkel, Michael Song, Alan M Mendelsohn, Iain B McInnes, on behalf of the PSUMMIT-1 and 2 Study Groups
• Extended report: Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis (25 April, 2013)

  Lihi Eder, Arane Thavaneswaran, Vinod Chandran, Dafna D Gladman
• Extended report: A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative (30 April, 2014) Free

  Laure Gossec, Maarten de Wit, Uta Kiltz, Juergen Braun, Umut Kalyoncu, Rossana Scrivo, Mara Maccarone, Laurence Carton, Kati Otsa, Imre Sooäär, Turid Heiberg, Heidi Bertheussen, Juan D Cañete, Anselm Sánchez Lombarte, Andra Balanescu, Alina Dinte, Kurt de Vlam, Josef S Smolen, Tanja Stamm, Dora Niedermayer, Gabor Békés, Douglas Veale, Philip Helliwell, Andrew Parkinson, Thomas Luger, Tore K Kvien, On behalf of the EULAR PsAID Taskforce
• Extended report: Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor (4 March, 2014)

  Arthur Kavanaugh, Philip J Mease, Juan J Gomez-Reino, Adewale O Adebajo, Jürgen Wollenhaupt, Dafna D Gladman, Eric Lespessailles, Stephen Hall, Marla Hochfeld, ChiaChi Hu, Douglas Hough, Randall M Stevens, Georg Schett
• Extended report: A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial (11 March, 2014)

  J L Nam, E Villeneuve, E M A Hensor, R J Wakefield, P G Conaghan, M J Green, A Gough, M Quinn, R Reece, S R Cox, M H Buch, D M van der Heijde, P Emery
• Extended report: Use of strontium ranelate and risk of acute coronary syndrome: cohort study (20 March, 2014)

  Henrik Svanström, Björn Pasternak, Anders Hviid
• Extended report: Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial (17 January, 2014)

  Nicola Dalbeth, Opetaia Aati, Gregory D Gamble, Anne Horne, Meaghan E House, Mark Roger, Anthony J Doyle, Ashika Chhana, Fiona M McQueen, Ian R Reid
• Extended report: MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome (6 July, 2013)

  Naomi I Maria, Zana Brkic, Matti Waris, Cornelia G van Helden-Meeuwsen, Kim Heezen, Joop P van de Merwe, Paul L van Daele, Virgil A S H Dalm, Hemmo A Drexhage, Marjan A Versnel
• Extended report: The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis (20 April, 2013)

  Tricia R Cottrell, Robert A Wise, Fredrick M Wigley, Francesco Boin
• Extended report: Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited (20 April, 2013)

  V Navarro-Compán, D van der Heijde, Harris A Ahmad, Colin G Miller, R Wolterbeek, R Landewé
• Extended report: A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks (19 April, 2013)

  Debby den Uyl, Marieke ter Wee, Maarten Boers, Pit Kerstens, Alexandre Voskuyl, Mike Nurmohamed, Hennie Raterman, Dirkjan van Schaardenburg, Nancy van Dillen, Ben Dijkmans, Willem Lems
• Extended report: High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis (3 May, 2013)

  X Baraliakos, N Baerlecken, T Witte, F Heldmann, J Braun
• Extended report: Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis (1 May, 2013)

  Clara Malattia, Maria Beatrice Damasio, Annalisa Madeo, Angela Pistorio, Anna Providenti, Silvia Pederzoli, Stefania Viola, Antonella Buoncompagni, Chiara Mattiuz, Agnese Beltramo, Alessandro Consolaro, Angelo Ravelli, Nicolino Ruperto, Paolo Picco, Gian Michele Magnano, Alberto Martini
• Extended report: The risk of atrial fibrillation in patients with rheumatoid arthritis (20 April, 2013)

  Seoyoung C Kim, Jun Liu, Daniel H Solomon
• Extended report: Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study (23 April, 2013)

  Camilla Bengtsson, Leonid Padyukov, Henrik Källberg, Saedis Saevarsdottir
• Extended report: Osteitis and synovitis, but not bone erosion, is associated with proteoglycan loss and microstructure damage in the cartilage of patients with rheumatoid arthritis (26 April, 2013)

  Barbara Herz, Andreas Albrecht, Matthias Englbrecht, Götz H Welsch, Michael Uder, Nina Renner, Philipp Schlechtweg, Dominik Paul, Lars Lauer, Klaus Engelke, Rolf Janka, Jürgen Rech, Georg Schett, Stephanie Finzel
• Extended report: The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial (3 May, 2013)

  Jürgen Braun, Xenofon Baraliakos, Kay-Geert A Hermann, Atul Deodhar, Désirée van der Heijde, Robert Inman, Anna Beutler, Yiying Zhou, Stephen Xu, Benjamin Hsu
• Extended report: Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study (21 May, 2013)

  Gerd Horneff, Ruben Burgos-Vargas, Tamas Constantin, Ivan Foeldvari, Jelena Vojinovic, Vyacheslav G Chasnyk, Joke Dehoorne, Violeta Panaviene, Gordana Susic, Valda Stanevica, Katarzyna Kobusinska, Zbigniew Zuber, Richard Mouy, Ingrida Rumba-Rozenfelde, Luciana Breda, Pavla Dolezalova, Chantal Job-Deslandre, Nico Wulffraat, Daniel Alvarez, Chuanbo Zang, Joseph Wajdula, Deborah Woodworth, Bonnie Vlahos, Alberto Martini, Nicolino Ruperto, for the Paediatric Rheumatology International Trials Organisation (PRINTO)
• Extended report: Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial (9 May, 2013)

  T W Jensen, M S Hansen, K Hørslev-Petersen, L Hyldstrup, B Abrahamsen, B Langdahl, B Zerahn, J Pødenphant, K Stengaard-Petersen, P Junker, M Østergaard, T Lottenburger, T Ellingsen, L S Andersen, I Hansen, H Skjødt, J K Pedersen, U B Lauridsen, A J Svendsen, U Tarp, H Lindegaard, Anne Grethe Jurik, Aage Vestergaard, M L Hetland, the Cimestra study group
• Extended report: Postoperative effects of neuromuscular exercise prior to hip or knee arthroplasty: a randomised controlled trial (9 May, 2013)

  Allan Villadsen, Søren Overgaard, Anders Holsgaard-Larsen, Robin Christensen, Ewa M Roos
• Extended report: A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies (11 May, 2013)

  Sandra Garcês, Marília Antunes, Elizabeth Benito-Garcia, José Canas da Silva, Lucien Aarden, Jocelyne Demengeot
• Extended report: Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus (5 May, 2013)

  Ben Parker, Awal Al-Husain, Philip Pemberton, Allen P Yates, Pauline Ho, Rachel Gorodkin, Lee Suan Teh, M Yvonne Alexander, Ian N Bruce
• Extended report: Primary Sjögren's syndrome and malignancy risk: a systematic review and meta-analysis (17 May, 2013)

  Yan Liang, Zaixing Yang, Baodong Qin, Renqian Zhong
• Extended report: Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers (14 June, 2013)

  Matteo Nicola Dario Di Minno, Rosario Peluso, Salvatore Iervolino, Anna Russolillo, Roberta Lupoli, Raffaele Scarpa, on behalf of the CaRRDs Study Group
• Extended report:

  A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis

  (21 May, 2013)

  D P C de Rooy, A Zhernakova, R Tsonaka, A Willemze, B A S Kurreeman, G Trynka, L van Toorn, R E M Toes, T W J Huizinga, J J Houwing-Duistermaat, P K Gregersen, A H M van der Helm-van Mil
• Extended report: Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls (28 May, 2013)

  Katherine P Liao, Dorothée Diogo, Jing Cui, Tianxi Cai, Yukinori Okada, Vivian S Gainer, Shawn N Murphy, Namrata Gupta, Daniel Mirel, Ashwin N Ananthakrishnan, Peter Szolovits, Stanley Y Shaw, Soumya Raychaudhuri, Susanne Churchill, Isaac Kohane, Elizabeth W Karlson, Robert M Plenge
• Concise report: A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients (9 August, 2013)

  Doruk Erkan, Rohan Willis, Vijaya L Murthy, Gurjot Basra, JoAnn Vega, Patricia Ruiz-Limón, Ana Laura Carrera, Elizabeth Papalardo, Laura Aline Martínez-Martínez, Emilio B González, Silvia S Pierangeli
• Concise report: Laser speckle contrast analysis: a new method to evaluate peripheral blood perfusion in systemic sclerosis patients (16 August, 2013)

  Barbara Ruaro, Alberto Sulli, Elisa Alessandri, Carmen Pizzorni, Giorgia Ferrari, Maurizio Cutolo
• Concise report: Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort (25 November, 2013)

  Liesbet Van Praet, Lennart Jans, Philippe Carron, Peggy Jacques, Elien Glorieus, Roos Colman, Heleen Cypers, Herman Mielants, Martine De Vos, Claude Cuvelier, Filip Van den Bosch, Dirk Elewaut
• Concise report: Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study (2 December, 2013)

  Pierluigi Macchioni, Luigi Boiardi, Mariagrazia Catanoso, Giulia Pazzola, Carlo Salvarani
• Concise report: Hip replacement surgery in patients with ankylosing spondylitis (27 November, 2013)

  Tone Wikene Nystad, Ove Furnes, Leif Ivar Havelin, Arne Kristian Skredderstuen, Stein Atle Lie, Bjørg-Tilde Svanes Fevang
• Concise report:

  Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis

  (17 December, 2013)

  H M Albers, T H C M Reinards, D M C Brinkman, S S M Kamphuis, M A J van Rossum, E PA H Hoppenreijs, H J Girschick, C Wouters, R K Saurenmann, E Bakker, W Verduijn, P Slagboom, T W J Huizinga, R E M Toes, J J Houwing-Duistermaat, R ten Cate, M W Schilham